COVID-19 ARDS: a review of imaging features and overview of mechanical ventilation and its complications

Emerg Radiol. 2022 Feb;29(1):23-34. doi: 10.1007/s10140-021-01976-5. Epub 2021 Oct 26.

Abstract

The first cluster of cases of COVID-19 pneumonia was reported on December 31, 2019. Since then, this disease has spread rapidly across the world, and as of September 17, 2021, there are 226,844,344 cases of COVID-19 worldwide with 4,666,334 deaths related to COVID-19. While most COVID-19 cases are mild, some cases are severe with patients developing acute respiratory distress syndrome (ARDS). The pathophysiology of ARDS includes damage to the alveolar epithelium that leads to increased permeability of the alveolar epithelial barrier causing hyaline membrane formation, interstitial edema, and alveolar edema that results in severe hypoxia. Patients with COVID-19 ARDS are supported by non-invasive or invasive mechanical ventilation with an aim to improve oxygenation and maintain adequate blood oxygen levels. Increased intra-alveolar pressure while on mechanical ventilation may lead to alveolar rupture and thus barotrauma-related injuries such as lung tension cysts, pulmonary interstitial emphysema (PIE), pneumomediastinum, pneumopericardium, and pneumothorax. Recent studies have shown that the rate of barotrauma-related events is higher in patients with COVID-19 ARDS compared to patients with ARDS secondary to other etiologies. Radiologists should be aware of the imaging features of COVID-19 ARDS as well as the complications of mechanical ventilation. This educational manuscript will review the features of COVID-19 ARDS, discuss imaging of patients on mechanical ventilation, and review the imaging features of complications related to mechanical ventilation, including ventilator-associated lung injuries.

Keywords: ARDS; Acute respiratory distress syndrome; Complications of mechanical ventilation; Covid-19 ARDS; Endotracheal intubation; Pneumomediastinum; Pneumothorax.

Publication types

  • Review

MeSH terms

  • COVID-19*
  • Humans
  • Oxygen Saturation
  • Respiration, Artificial / adverse effects
  • Respiratory Distress Syndrome* / diagnostic imaging
  • Respiratory Distress Syndrome* / therapy
  • SARS-CoV-2